alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › facilitate

facilitate

4 studies tagged facilitate, dated 2000-06-01 to 2021-06-26. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Transitioning from cerebrospinal fluid to blood tests to facilitate diagnosis and disease monitoring in Alzheimer's disease 2021-06-26
  2. ApoE facilitates the microglial response to amyloid plaque pathology 2018-02-26
  3. Blood-Based Oligomeric and Other Protein Variant Biomarkers to Facilitate Pre-Symptomatic Diagnosis and Staging of Alzheimer's Disease 2017-01-01

Studies

4 studies carry this tag.

Date range

2000 to 2021

Top journals

  • Annals of neurology 1
  • Journal of Alzheimer's disease : JAD 1
  • Journal of internal medicine 1
  • The Journal of experimental medicine 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Transitioning from cerebrospinal fluid to blood tests to facilitate diagnosis and disease monitoring in Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Journal of internal medicine 2021-06-26 Biomarkers

    Alzheimer's disease (AD) is increasingly prevalent worldwide, and disease-modifying treatments may soon be at hand; hence, now, more than ever, there is a need to develop techniques that allow earlier and more secure diagnosis.

  2. ApoE facilitates the microglial response to amyloid plaque pathology

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. The Journal of experimental medicine 2018-02-26 Genetics

    One of the hallmarks of Alzheimer's disease is the presence of extracellular diffuse and fibrillar plaques predominantly consisting of the amyloid-β (Aβ) peptide.

  3. Blood-Based Oligomeric and Other Protein Variant Biomarkers to Facilitate Pre-Symptomatic Diagnosis and Staging of Alzheimer's Disease

    ✓ Peer-reviewed alzhub usefulness score 53 out of 100. Journal of Alzheimer's disease : JAD 2017-01-01 Biomarkers

    Oligomeric forms of amyloid-β (Aβ), tau, and TDP-43 play important roles in Alzheimer's disease (AD), and therefore are promising biomarkers.

  4. Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease model

    ✓ Peer-reviewed alzhub usefulness score 40 out of 100. Annals of neurology 2000-06-01 Genetics

    The epsilon4 allele of apolipoprotein E (ApoE) is an important genetic risk factor for Alzheimer's disease (AD).

All topic tags with their study counts